Haibang Capital

Zhejiang Haibang Investment Management Co., Ltd., commonly known as Haibang Capital, is a private equity and venture capital firm established in 2010 in Hangzhou, China. The firm specializes in investing in startups and companies at various stages of development, including early and growth stages, with a focus on emerging industries such as biomedicine, new materials, new energy, environmental protection, digital information, and advanced manufacturing. Haibang Capital emphasizes support for returnee entrepreneurs—those who have studied or worked abroad and are starting businesses in China. In 2011, the firm launched its first fund aimed at assisting these returnees, thereby contributing to local economic growth and innovation. Beyond financial investment, Haibang Capital offers personalized value-added services to its portfolio companies, fostering both economic and social benefits in the Zhejiang Province and beyond.

Shan Jialiang

MD

Gang Liang

Founding Partner

Li Xie

President

Naxin Yao

Chairman and Executive Partner

39 past transactions

Jianxin Jiaren

Series A in 2024
Jianxin Jiaren is a manufacturing business that creates and markets chemical products and raw materials. It uses a chemical recycling system, discarded waste textiles, and uses chemical decomposition technology to reduce waste polyester materials into small chemical molecules. It reduces dependence on petroleum resources and waste generation.

Jinmate

Series B in 2024
Jinmate focuses on manufacturing and provides customers with stable and efficient digital intelligent manufacturing overall solutions.

MetaLenX

Series A in 2023
MetaLenX is a manufacturer of planar optical devices, specifically metalenses, utilizing advanced semiconductor technology for large-scale production. These metalenses feature micro-nano structures that modulate the phase of incident light and are designed to operate across a broad spectrum, from visible light to infrared wavelengths. The company aims to apply its innovative metalens technology in various sectors, including consumer electronics, security monitoring, automotive electronics, 5G infrastructure, augmented and virtual reality, and drones. By focusing on customization and mass production, MetaLenX plays a significant role in advancing optical technology and enhancing applications across multiple industries.

LYNK Pharmaceuticals

Series C in 2023
LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.

Zhiwei Technology

Venture Round in 2023
Zhiwei Technology provides microporous foam sheets made of polymer supercritical microcellular foaming that are lightweight and durable.

Zhongzhiwei Technology

Series A in 2023
Zhongzhiwei Technology is an emerging provider of artificial intelligence and machine learning-driven solutions for network security. The company focuses on enhancing the security landscape in China by offering comprehensive services across various sectors, including finance, public safety, government, manufacturing, and enterprise-level information security. Its portfolio comprises high-quality network security services, a platform for large-scale attack and defense training collaboration, and knowledge graph-based security solutions. By leveraging advanced technologies, Zhongzhiwei Technology aims to promote the development of the network security industry and address the evolving challenges faced by organizations in protecting their data and infrastructures.

Jinmate

Series A in 2023
Jinmate focuses on manufacturing and provides customers with stable and efficient digital intelligent manufacturing overall solutions.

Microquanta

Series D in 2022
Microquanta, based in Hangzhou, specializes in the development and manufacturing of perovskite solar cell modules, which represent an innovative approach to solar technology. These modules are designed to deliver higher electricity conversion rates at lower costs compared to traditional solar technologies. The company's latest perovskite mini-module achieves an electricity conversion rate of 17%, surpassing its previous record of 16%. With a total funding of $10 million secured, Microquanta aims to further commercialize its technology and establish production lines within the year. By offering high energy conversion efficiency, the company provides flexible clean energy solutions to its business clients.

Healsun Biopharm

Series B in 2022
Healsun Biopharm is a biopharmaceutical company based in Hangzhou, China, specializing in research and development services for new drug development. Founded in 2015, the company offers a range of services including molecular construction, stable cell line screening, cell culture process development, protein purification, and bioanalytical method development. Healsun Biopharm focuses on preclinical drug development, providing essential technical services to global biopharmaceutical and biotechnology firms. Its platform supports antibody drug analysis, transient protein expression, and the development of antibody-conjugated drugs, enabling clients to accelerate their research processes and minimize costs.

Hengyu Biotechnology

Series A in 2022
Hengyu Biotechnology is a specialized provider of biological testing services aimed at drug developers. Founded by a scientific research team, the company focuses on delivering comprehensive biosafety testing solutions for innovative pharmaceutical companies worldwide. Its services include viral clearance process validation, cell bank validation, replicative virus testing, batch release testing, CGT bioanalysis, and process residue testing. These offerings are designed to meet regulatory filing requirements across the United States, China, and Europe, supporting the entire life cycle of biologics from research and development to marketing.

JH Cispoly

Series A in 2022
JH Cispoly specializes in the development of diagnostic technology and equipment specifically aimed at the early detection of gynecological tumors. The company focuses on innovative solutions for identifying ovarian, cervical, and endometrial cancers, among others. By enhancing the capabilities for early diagnosis, JH Cispoly plays a crucial role in improving patient outcomes through timely intervention in gynecological health.

DECANS

Series B in 2022
DECANS manufactures medical devices that include spine, artificial joints, and trauma systems, data acquisition, processing, and analysis systems, 3D bionic additive manufacturing for medical devices. They provide medical device design and demonstration training centers.

Jiu Zong

Series B in 2021
Jiu Zong offers main products such as include three-dimensional shape measuring instruments, LED chip packaging appearance inspection equipment, mobile phone glass cover appearance inspection equipment, mobile phone middle frame glue line inspection equipment, mobile phone middle frame flatness, straightness inspection equipment, injection molded parts Professional 3D measurement and appearance inspection equipment such as appearance inspection equipment, and sheet metal online inspection equipment.

Odianyun

Series C in 2021
Odianyun, officially known as Haiou Electric Cloud Information Technology Co., Ltd., is a leading provider of cross-platform e-commerce system cloud services and solutions. Established in 2015, the company specializes in the research and development of large-scale e-commerce systems that encompass back-end supply chain management and e-commerce websites. Odianyun focuses on omnichannel operations, including PC, mobile, and in-store solutions, by offering a comprehensive SaaS-based business platform. This platform is designed to enhance operational efficiency for vendors by integrating advanced retail management tools and facilitating better communication across various channels. Odianyun aims to assist traditional businesses in transforming their operations for the digital age, promoting the concept of "Internet +" while emphasizing social value and strategic collaboration. With a dedicated team, the company strives to meet the evolving demands of the e-commerce landscape.

T-Maximum

Angel Round in 2021
T-Maximum is a biotechnology company focused on developing CAR-T cell therapies specifically for the treatment of brain tumors. The company utilizes an innovative gene-editing platform based on CRISPR/Cas9 technology, which enables the creation of allogeneic CAR-T cells that can effectively address significant challenges in the field, such as graft-versus-host disease and immune rejection. T-Maximum's unique approach offers a universal CAR-T therapy, allowing for a more accessible and effective treatment option for patients. The allogeneic immune cells developed by T-Maximum have demonstrated the capability to persist in patients over extended periods and have shown promising therapeutic results, providing new hope for those affected by brain tumors.

TYK Medicines

Series B in 2021
TYK Medicines, Inc. is a biotechnology company established in 2017 and headquartered in Shanghai, China. It focuses on the research and development of anti-cancer drugs and operates various laboratory facilities, including biological, cell culture, analysis, and chemical analysis laboratories. The company is dedicated to discovering and developing new pharmaceutical products aimed at addressing unmet medical needs in oncology. Through its innovative approaches in drug research and development, TYK Medicines strives to advance the field of cancer treatment.

Healsun Biopharm

Series A in 2021
Healsun Biopharm is a biopharmaceutical company based in Hangzhou, China, specializing in research and development services for new drug development. Founded in 2015, the company offers a range of services including molecular construction, stable cell line screening, cell culture process development, protein purification, and bioanalytical method development. Healsun Biopharm focuses on preclinical drug development, providing essential technical services to global biopharmaceutical and biotechnology firms. Its platform supports antibody drug analysis, transient protein expression, and the development of antibody-conjugated drugs, enabling clients to accelerate their research processes and minimize costs.

YIBEI

Series A in 2021
YIBEI is a medical technology company based on digital services. They are passionate about the use of artificial intelligence, big data, and cloud computing technologies to strengthen the medical and health industries. YIBEI provides hospital management platforms, e-commerce platforms, financial platforms, and supplier material management platforms, integrating the scientific into the interconnected industrial environment of the entire industrial chain.

Sciwind Biosciences

Series B in 2021
Hangzhou Sciwind Biosciences Co., Ltd. is a biotechnology company that focuses on the development and commercialization of protein and peptide-based drugs aimed at treating various diseases. Founded in 2017 and located in Hangzhou, China, the company targets multiple therapeutic areas, including diabetes, obesity, metabolic liver diseases, diabetic retinopathy, and neurodegenerative disorders. Sciwind's innovative drug candidates are particularly designed to address metabolic disorders, including non-alcoholic steatohepatitis, providing enhanced treatment options for physicians and their patients.

Dangwu

Series A in 2021
Dangwu is a big data platform that has helped many customers in industries such as electric power, the chemical industry, transportation, government affairs, and retail realize domestic substitution.

Joinhealth Technology

Series A in 2019
Hangzhou Joinhealth Technology Co., Ltd. specializes in developing software solutions for medical follow-up and post-hospital management. Founded in 2015 and headquartered in Hangzhou, China, the company offers a range of products including systems for hospital follow-up, VIP customer management, chronic disease management, and maternal and child health. Joinhealth Technology integrates artificial intelligence and advanced technologies like the Internet and Internet of Things to enhance patient management. By shifting the focus from disease treatment to comprehensive disease management, the company facilitates intelligent management of patients throughout their healthcare journey, from hospital care to home and potential re-admission.

Jianhai Technology

Series A in 2019
Jianhai Technology is an AI whole-course management platform that provides users with post-hospital & post-diagnosis management services.

Yidianling

Series A in 2018
Yidianling is a psychological counselling platform that provides free mental health services such as free questions and answers, psychological tests, expert services, and training lectures.

TranslateGo

Angel Round in 2017
TranslateGo is a company focused on delivering advanced translation services through a platform that utilizes artificial intelligence and big data. It offers a range of solutions, including automated document translation, human translation, and plagiarism checks. The company aims to enhance the reading experience for its users by providing accurate translations in nearly 100 different languages. TranslateGo's innovative approach incorporates a neural network intelligent translation system, ensuring high-quality and efficient service for clients in need of reliable translation solutions.

YIBEI

Angel Round in 2017
YIBEI is a medical technology company based on digital services. They are passionate about the use of artificial intelligence, big data, and cloud computing technologies to strengthen the medical and health industries. YIBEI provides hospital management platforms, e-commerce platforms, financial platforms, and supplier material management platforms, integrating the scientific into the interconnected industrial environment of the entire industrial chain.

Realy Technology

Series A in 2017
Realy Technology is a medical equipment and device manufacturing company that specializes in developing at-home diagnostic devices. The firm focuses on point-of-care testing (POCT) products that enable rapid medical testing, providing patients with immediate diagnostic information about their health conditions. This capability allows individuals to make informed medical decisions promptly, enhancing the overall efficiency of healthcare delivery.

Power Data

Series A in 2016
Baohe Data is a technological big data and artificial intelligence service provider. They provide digital services such as discipline construction, scientific research, talent training, quality management, achievement transformation, and the integration of production and education. It offers services for education authorities, universities, and technology enterprise R and D institutions.

e-LinkCare

Series A in 2016
e-LinkCare is a tech company that manufactures medical equipment, including the AccuGenceTM multi-monitoring system and the UBREATHTM spirometer system, as well as integrated digital and mobile healthcare solutions. They provide solutions for respiratory diseases, cardiovascular diseases, and metabolic diseases. They provide comprehensive chronic disease solutions for professional and home care.

DECANS

Angel Round in 2016
DECANS manufactures medical devices that include spine, artificial joints, and trauma systems, data acquisition, processing, and analysis systems, 3D bionic additive manufacturing for medical devices. They provide medical device design and demonstration training centers.

IMPACT Therapeutics

Series B in 2016
IMPACT Therapeutics, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapeutics for cancer and other life-threatening diseases. Founded in 2009 and based in Shanghai, China, the company focuses on creating targeted anti-cancer treatments utilizing synthetic lethality. IMPACT Therapeutics is actively engaged in several research and development projects, including a PARP inhibitor, a Wee1 inhibitor, and various novel agents targeting DNA damage response mechanisms and the Hedgehog signaling pathway. Through its commitment to advancing treatment options, IMPACT Therapeutics aims to provide patients with effective and targeted anti-cancer therapies.

Realy Technology

Angel Round in 2015
Realy Technology is a medical equipment and device manufacturing company that specializes in developing at-home diagnostic devices. The firm focuses on point-of-care testing (POCT) products that enable rapid medical testing, providing patients with immediate diagnostic information about their health conditions. This capability allows individuals to make informed medical decisions promptly, enhancing the overall efficiency of healthcare delivery.

Scooper Technology

Series A in 2015
Scooper Technology specializes in providing comprehensive solutions and services for the public security industry. The company focuses on the development, research, production, and sales of public security emergency platform software and hardware. Its service areas encompass urban emergency response, urban lifeline monitoring projects, earthquake disaster mitigation, public health, grassroots governance, and intelligent systems for civil air defense, mining, and parks. Through its innovative approach, Scooper Technology aims to enhance public safety and improve emergency response capabilities across various sectors.

Zylox Medical Device

Series A in 2015
Zylox Medical Device Co., founded in 2012 in Hangzhou, is a specialized company focused on developing innovative medical devices for interventional procedures. Established by a team of experienced professionals with backgrounds in top-tier medical device manufacturers, Zylox offers a diverse range of products primarily aimed at peripheral vascular and neurovascular interventions. Its product line includes various devices such as PTA balloons, drug-coated PTA balloons, superficial femoral artery (SFA) stents, and the Thrombite Clot Retriever Device. Zylox is committed to improving patient outcomes by consistently enhancing its cutting-edge medical technologies and ensuring the highest quality standards.

Techbridge

Series C in 2015
Techbridge is a research and development company for the triple-play video communication platform and its applications in different fields. It has been deeply integrated with a number of industrial applications and launched a series of industries that provide audio and video services.

InnoTek

Series A in 2015
Zhejiang InnoTek Co., Ltd. is engaged in the development of wireless sensor technology products tailored for Internet-of-Things applications and personal positioning services. The company specializes in smart parking management and guidance systems, judicial community correction systems, and integrated personal positioning monitoring systems. Its offerings are utilized across various sectors, including smart traffic management and smart judicature. InnoTek's software solutions encompass parking information collection, unified charging management, and intelligent toll terminal charging management, which facilitate efficient parking management for car park owners and policymakers. Established in 2011 and headquartered in Hangzhou, China, InnoTek collaborates strategically with prominent telecommunications companies to enhance its technology and service offerings.

Gunma Wangluo

Angel Round in 2015
Gunma Wangluo provides management software, wechat ecological mini program, and hardware equipment services. They also provide billing and flexible management of stores.

Zannan

Series C in 2015
Zannan Technology is a fast-growing high-tech company focused on scientific and technological innovation, and it is dedicated to the research and development, production, and sale of high-performance catalysts and new polymer materials.

Das Security

Angel Round in 2011
Das Security is a provider of information security technology services, offering many comprehensive solutions like application security, database security, website security monitoring, and a digital security management platform. The company maintains its corporate purpose of creating a safe and credible digital world, supports, customer success, responsibility first, open innovation, and people-oriented, common growth as the company's values, and positions itself as the security cornerstone of digitalization. It is committed to leading the global digital security industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.